PATENT CLAIM ANALYSIS

Application Number: 16144394
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "210100"]

Abstract:
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines (NAVs) comprising polynucleotide molecules encoding one or more antigens.

Claim (Index 14):
The nucleic acid vaccine of  claim 1 , wherein at least 80% of the uracil in the open reading frame have a chemical modification.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.03448
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15091123', '16136503', '15674591', '15674585', '16136386']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.776490960140801
- 35 USC 102 Novelty (BERT): 0.632535446424285
- Combined Prediction Score: 0.7620954087691494
- Mean Citation Score: 448.80863800000014
- Max Citation Score: 621.3409
- Similarity Product: 544.3420249491273

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test